Puncture Template Assisted Biopsy for Pulmonary Nodules
Primary Purpose
Pulmonary Nodule, CT Guided Biopsy
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
CT guided biopsy for pulmonary nodule
Sponsored by
About this trial
This is an interventional prevention trial for Pulmonary Nodule focused on measuring pulmonary nodule, biopsy, puncture template
Eligibility Criteria
Inclusion Criteria:
- Single or multiple pulmonary nodules (solid, partially solid, pure ground glass), with the maximum diameter of 5mm to 20mm and need for pathological diagnosis.
- No drugs affecting blood coagulation and (or) platelet aggregation were used; if used, the drugs had been stopped for enough time according to the drug elution period.
- KPS > 60, no serious or uncontrollable underlying diseases, the patients can tolerate lung puncture according to clinical evaluation.
- There is an appropriate puncture path.
Exclusion Criteria:
- Poor lung function (such as FEV1 < 40% in the first second and / or DLCO < 50%) and / or isolated pulmonary bullae on the puncture path.
- The nodule is close to small airway and blood vessels, or has pulmonary hypertension and superior vena cava compression, so the risk of puncture bleeding and hemoptysis is expected to be high.
- Poor compliance, unable to complete the cooperation.
- Due to other reasons which is not suitable to participate in this clinical trial.
Sites / Locations
- Peking University Third HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Puncture Template and CT group
CT group
Arm Description
Puncture Template assisted CT guided lung biopsy was performed.
Simple CT guided lung biopsy was performed.
Outcomes
Primary Outcome Measures
Puncture accuracy assessed by direct measurement.
The distance between the actual puncture point and the expected puncture point should be measured on CT image, to get whether there are any errors in the needle insertion of the two groups and whether there are differences between the two groups.
Secondary Outcome Measures
Success rate of first needle puncture assessed by freqencey of needle adjustment.
The freqencey of times of needle adjustment should be recorded. If the frequency of puncture needle adjustment is 0, the first needle puncture was recorded as successful. If the frequency of needle adjustment is not 0, the number of times of needle adjustment should be recorded.
Complications assessed by CTCAE 5.0
The incidence and severity of complications such as pneumothorax, subcutaneous emphysema, hemothorax, hemoptysis and air embolism should be recorded.
Operation time assessed by direct timing.
The time from the first CT scan to the last CT scan should be recorded.
Times of CT scans assessed by direct counting.
The total number of CT scans throughout the operation should be recorded.
Pathological report issued by pathology department.
The pathological results (pathological report issued by pathology department) of puncture should be followed up and recorded. If the pathological results indicate normal tissue/structure, the puncture result is considered to be negative.
Full Information
NCT ID
NCT04890301
First Posted
April 30, 2021
Last Updated
August 9, 2022
Sponsor
Peking University Third Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04890301
Brief Title
Puncture Template Assisted Biopsy for Pulmonary Nodules
Official Title
Puncture Template Assisted CT Guided Versus Simple CT Guided Biopsy for Small Pulmonary Nodules: a Multicenter, Prospective, Randomized Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
December 30, 2022 (Anticipated)
Study Completion Date
May 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Peking University Third Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Pulmonary nodules are small in size and easy to move with breathing. CT guided puncture is highly dependent on the personal experience of physicians, that is, the accuracy, efficiency and incidence of complications of puncture vary greatly among physicians.
Puncture template (PT) assisted CT guided needle biopsy of pulmonary nodules has good clinical feasibility, which is expected to make up for the deficiency of simple CT guided needle biopsy, and make the needle biopsy of pulmonary nodules more accurate and standardized.
This study intends to carry out a randomized controlled study to further evaluate the safety and effectiveness of PT assisted CT guided needle biopsy of pulmonary nodules, and provide higher quality data reference for its clinical application.
Patients were randomly divided into two groups: PT assisted CT guided or simple CT guided lung biopsy. The operation related information, complications and postoperative pathological results of the two groups were collected.
Primary end point: puncture accuracy Secondary end point: success rate of first needle puncture; complication rate (such as pneumothorax, bleeding, etc.); operation time; CT scan times; pathologic findings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Nodule, CT Guided Biopsy
Keywords
pulmonary nodule, biopsy, puncture template
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
266 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Puncture Template and CT group
Arm Type
Experimental
Arm Description
Puncture Template assisted CT guided lung biopsy was performed.
Arm Title
CT group
Arm Type
Active Comparator
Arm Description
Simple CT guided lung biopsy was performed.
Intervention Type
Behavioral
Intervention Name(s)
CT guided biopsy for pulmonary nodule
Intervention Description
The technical process of the experimental group: ① design of puncture path, positioning and fixation of patients; ② puncture point positioning; ③ installation of navigation frame and template; ④ percutaneous lung biopsy guided by PT combined with CT.
The technical process of the active comparator group: ① planning puncture path, positioning and fixation of patients; ② positioning puncture point; ③ CT guided percutaneous lung biopsy.
The operation related information, complications and postoperative pathological results were collected.
Primary Outcome Measure Information:
Title
Puncture accuracy assessed by direct measurement.
Description
The distance between the actual puncture point and the expected puncture point should be measured on CT image, to get whether there are any errors in the needle insertion of the two groups and whether there are differences between the two groups.
Time Frame
Immediately after the operation (puncture).
Secondary Outcome Measure Information:
Title
Success rate of first needle puncture assessed by freqencey of needle adjustment.
Description
The freqencey of times of needle adjustment should be recorded. If the frequency of puncture needle adjustment is 0, the first needle puncture was recorded as successful. If the frequency of needle adjustment is not 0, the number of times of needle adjustment should be recorded.
Time Frame
Immediately after the operation (puncture).
Title
Complications assessed by CTCAE 5.0
Description
The incidence and severity of complications such as pneumothorax, subcutaneous emphysema, hemothorax, hemoptysis and air embolism should be recorded.
Time Frame
From the beginning of operation to 1 month after operation (puncture).
Title
Operation time assessed by direct timing.
Description
The time from the first CT scan to the last CT scan should be recorded.
Time Frame
Immediately after the operation (puncture).
Title
Times of CT scans assessed by direct counting.
Description
The total number of CT scans throughout the operation should be recorded.
Time Frame
Immediately after the operation (puncture).
Title
Pathological report issued by pathology department.
Description
The pathological results (pathological report issued by pathology department) of puncture should be followed up and recorded. If the pathological results indicate normal tissue/structure, the puncture result is considered to be negative.
Time Frame
1 week to 1 month after operation (puncture).
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Single or multiple pulmonary nodules (solid, partially solid, pure ground glass), with the maximum diameter of 5mm to 20mm and need for pathological diagnosis.
No drugs affecting blood coagulation and (or) platelet aggregation were used; if used, the drugs had been stopped for enough time according to the drug elution period.
KPS > 60, no serious or uncontrollable underlying diseases, the patients can tolerate lung puncture according to clinical evaluation.
There is an appropriate puncture path.
Exclusion Criteria:
Poor lung function (such as FEV1 < 40% in the first second and / or DLCO < 50%) and / or isolated pulmonary bullae on the puncture path.
The nodule is close to small airway and blood vessels, or has pulmonary hypertension and superior vena cava compression, so the risk of puncture bleeding and hemoptysis is expected to be high.
Poor compliance, unable to complete the cooperation.
Due to other reasons which is not suitable to participate in this clinical trial.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zhe Ji
Phone
+8618710002823
Email
aschoff@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Junjie Wang
Organizational Affiliation
Peking University Third Hospital, Department of Radiation Oncology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking University Third Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100191
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhe Ji
Phone
+8618710002823
Email
aschoff@163.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
IPD will be available to other researchers and can be requested by the email of study sponsor.
IPD Sharing Time Frame
Data will be available within 2 years of the study completion.
IPD Sharing Access Criteria
The purpose needs to be informed to and judged by the research sponsor. Requestors will be required to sign a Data Access Agreement.
Learn more about this trial
Puncture Template Assisted Biopsy for Pulmonary Nodules
We'll reach out to this number within 24 hrs